
Mereo BioPharma Group plc MREO
$ 0.32
1.3%
Annual report 2022
added 12-21-2024
Mereo BioPharma Group plc P/E Ratio 2011-2026 | MREO
Annual P/E Ratio Mereo BioPharma Group plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.391 | -1.68 | - | - | - | - | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.391 | -1.68 | -1.04 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.35 | -2.91 % | $ 359 M | ||
|
Coherus BioSciences
CHRS
|
1.35 | $ 1.61 | -3.59 % | $ 189 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
14.2 | $ 24.88 | -0.4 % | $ 3.04 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-1.62 | $ 10.02 | -1.16 % | $ 133 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Cardiff Oncology
CRDF
|
-2.54 | $ 1.57 | -0.63 % | $ 105 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.65 | 1.3 % | $ 8.78 B | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
DBV Technologies S.A.
DBVT
|
-19.2 | $ 20.25 | -0.54 % | $ 2.83 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.55 | -4.14 % | $ 16 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Dyadic International
DYAI
|
-4.27 | $ 0.87 | - | $ 31.5 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Entera Bio Ltd.
ENTX
|
-3.06 | $ 1.17 | -2.1 % | $ 64 M | ||
|
Equillium
EQ
|
-5.27 | $ 2.0 | -0.5 % | $ 115 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Evogene Ltd.
EVGN
|
-2.18 | $ 0.8 | 2.49 % | $ 27.9 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Fate Therapeutics
FATE
|
-1.37 | $ 1.15 | -3.78 % | $ 137 M | ||
|
Forte Biosciences
FBRX
|
-4.83 | $ 26.15 | -1.1 % | $ 339 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Fennec Pharmaceuticals
FENC
|
-17.3 | $ 6.2 | -3.43 % | $ 177 M | ||
|
Foghorn Therapeutics
FHTX
|
-4.79 | $ 4.75 | -2.59 % | $ 299 M | ||
|
Amicus Therapeutics
FOLD
|
-163 | $ 14.46 | 0.03 % | $ 4.46 B | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 88.37 | -3.19 % | $ 27.2 B | ||
|
Akari Therapeutics, Plc
AKTX
|
-467 | $ 3.52 | -0.56 % | $ 237 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Fulcrum Therapeutics
FULC
|
-0.0072 | $ 7.45 | -4.85 % | $ 472 K | ||
|
Galectin Therapeutics
GALT
|
-5.78 | $ 2.38 | -7.03 % | $ 152 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
130 | $ 315.4 | -4.52 % | $ 41.3 B | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Gilead Sciences
GILD
|
21.6 | $ 138.37 | -1.26 % | $ 172 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.166 | $ 0.54 | 4.26 % | $ 503 K | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
Genmab A/S
GMAB
|
33.2 | $ 27.13 | -2.25 % | $ 17 B | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M |